Beta blockade during and after myocardial infarction: an overview of the randomized trials

S Yusuf, R Peto, J Lewis, R Collins, P Sleight - Progress in cardiovascular …, 1985 - Elsevier
An imbalance in oxygen supply and demand......................................................................... 337
Experimental evidence for possible mechanisms of benefit from beta blockade in acute MI …

Uses and abuses of meta-analysis

M Egger, GD Smith, JAC Sterne - Clinical Medicine, 2001 - Elsevier
Meta-analysis, the statistical combination of results from several studies to produce a single
estimate of the effect of a treatment, continues to attract controversy. We illustrate the …

Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial

Å Hjalmarson, J Herlitz, I Malek, L Ryden, A Vedin… - The Lancet, 1981 - Elsevier
The effect of metoprolol on mortality was compared with that of placebo in a double-blind
randomised trial in patients with definite or suspected acute myocardial infarction. Treatment …

Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials

S Bangalore, H Makani, M Radford, K Thakur… - The American journal of …, 2014 - Elsevier
Background Debate exists about the efficacy of β-blockers in myocardial infarction and their
required duration of usage in contemporary practice. Methods We conducted a …

Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis

AM Thompson, T Hu, CL Eshelbrenner, K Reynolds… - Jama, 2011 - jamanetwork.com
Context Cardiovascular disease (CVD) risk increases beginning at systolic blood pressure
levels of 115 mm Hg. Use of antihypertensive medications among patients with a history of …

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

JK Kjekshus - The American journal of cardiology, 1986 - Elsevier
Heart rate after an acute myocardial infarction (AMI) is an index of late mortality. The
hypothesis—that the potential beneficial effect of β-blocking drugs after an AMI is …

Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical …

M Cucherat - European heart journal, 2007 - academic.oup.com
Aims The impact on mortality outcomes of beta-blockers and calcium blockers in post-
myocardial infarction (MI) has been suggested to be related to resting heart rate (HR) …

Controlled trial of sotalol for one year after myocardial infarction

DG Julian, FS Jackson, RJ Prescott, P Szekely - The Lancet, 1982 - Elsevier
In a multicentre double-blind randomised study, the effect of sotalol 320 mg once daily was
compared with that of placebo in patients surviving an acute myocardial infarction …

Cardiovascular drug class specificity: β-blockers

MJ Reiter - Progress in cardiovascular diseases, 2004 - Elsevier
β-Adrenergic blockers are one of the most frequently prescribed cardiovascular drugs.
Numerous β-blockers are available for clinical use. Although these agents differ …

The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease

RM Carney, MW Rich, A TeVelde, J Saini… - Journal of …, 1988 - Elsevier
Seventy-seven patients undergoing elective cardiac catheterization were administered a
diagnostic psychiatric interview and their mean heart rates and heart rate variability were …